Trial Profile

Phase I trial of APPA in patients with osteoarthritis.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Sep 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Apocynin/paeonol (Primary)
Indications Osteoarthritis
Focus Adverse reactions; Therapeutic Use

Most Recent Events

18 Sep 2020 According to a AKL Research and development media release, a National Institute for Health Research (NIHR)-approved this phase I study was successfully completed earlier this year at the University of Liverpool in the UK. The full study report will be available shortly.
18 Sep 2020 Status changed from recruiting to completed, according to a AKL Research and development media release.
22 Feb 2019 According to the AKL Research and development media release, this trial is being conducted at Liverpool University's Institute of Ageing and Chronic Disease and Professor Robert Moots is leading this trial.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com